CAR- T as well as cell gene treatments are too expensive

.Nature Medicine, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manufacturing and also technology transmission can provide cellular gene therapies at a budget-friendly cost to patients across the planet.